Global Tumor Marker Testing Market Research Report 2024

Publication ID:

PB502242137

Publication Date:

March 5, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease.
The global Tumor Marker Testing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
During the next five years, the worldwide cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated technological breakthroughs will create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise in geriatric population will further compound the growing demand for malignancy assays and the rapid market expansion worldwide.
This report aims to provide a comprehensive presentation of the global market for Tumor Marker Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tumor Marker Testing.
Report Scope
The Tumor Marker Testing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Tumor Marker Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Tumor Marker Testing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott Diagnostics
Affymetrix
Agilent Technologies
Beckman Dickinson锛圔D锛�
BioCurex
BioModa
Clarient
Correlogic Systems
Epigenomics
Hologic
Roche Diagnostics
Segment by Type
Biochemical Markers
Oncogenes
Growth Factors
Hormones
Colony Stimulating Factors
Lymphokines
Immunohistochemical Stains
Others
Segment by Application
Hospitals
Commercial/Private Laboratories
Physician Offices/Group Practices
Cancer Clinics
Ambulatory Care Centers
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Tumor Marker Testing companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Tumor Marker Testing Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Biochemical Markers
1.2.3 Oncogenes
1.2.4 Growth Factors
1.2.5 Hormones
1.2.6 Colony Stimulating Factors
1.2.7 Lymphokines
1.2.8 Immunohistochemical Stains
1.2.9 Others
1.3 Market by Application
1.3.1 Global Tumor Marker Testing Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Commercial/Private Laboratories
1.3.4 Physician Offices/Group Practices
1.3.5 Cancer Clinics
1.3.6 Ambulatory Care Centers
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Tumor Marker Testing Market Perspective (2019-2030)
2.2 Tumor Marker Testing Growth Trends by Region
2.2.1 Global Tumor Marker Testing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Tumor Marker Testing Historic Market Size by Region (2019-2024)
2.2.3 Tumor Marker Testing Forecasted Market Size by Region (2025-2030)
2.3 Tumor Marker Testing Market Dynamics
2.3.1 Tumor Marker Testing Industry Trends
2.3.2 Tumor Marker Testing Market Drivers
2.3.3 Tumor Marker Testing Market Challenges
2.3.4 Tumor Marker Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Tumor Marker Testing Players by Revenue
3.1.1 Global Top Tumor Marker Testing Players by Revenue (2019-2024)
3.1.2 Global Tumor Marker Testing Revenue Market Share by Players (2019-2024)
3.2 Global Tumor Marker Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Tumor Marker Testing Revenue
3.4 Global Tumor Marker Testing Market Concentration Ratio
3.4.1 Global Tumor Marker Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Tumor Marker Testing Revenue in 2023
3.5 Tumor Marker Testing Key Players Head office and Area Served
3.6 Key Players Tumor Marker Testing Product Solution and Service
3.7 Date of Enter into Tumor Marker Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Tumor Marker Testing Breakdown Data by Type
4.1 Global Tumor Marker Testing Historic Market Size by Type (2019-2024)
4.2 Global Tumor Marker Testing Forecasted Market Size by Type (2025-2030)
5 Tumor Marker Testing Breakdown Data by Application
5.1 Global Tumor Marker Testing Historic Market Size by Application (2019-2024)
5.2 Global Tumor Marker Testing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Tumor Marker Testing Market Size (2019-2030)
6.2 North America Tumor Marker Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Tumor Marker Testing Market Size by Country (2019-2024)
6.4 North America Tumor Marker Testing Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Tumor Marker Testing Market Size (2019-2030)
7.2 Europe Tumor Marker Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Tumor Marker Testing Market Size by Country (2019-2024)
7.4 Europe Tumor Marker Testing Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Tumor Marker Testing Market Size (2019-2030)
8.2 Asia-Pacific Tumor Marker Testing Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Tumor Marker Testing Market Size by Region (2019-2024)
8.4 Asia-Pacific Tumor Marker Testing Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Tumor Marker Testing Market Size (2019-2030)
9.2 Latin America Tumor Marker Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Tumor Marker Testing Market Size by Country (2019-2024)
9.4 Latin America Tumor Marker Testing Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Tumor Marker Testing Market Size (2019-2030)
10.2 Middle East & Africa Tumor Marker Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Tumor Marker Testing Market Size by Country (2019-2024)
10.4 Middle East & Africa Tumor Marker Testing Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Diagnostics
11.1.1 Abbott Diagnostics Company Detail
11.1.2 Abbott Diagnostics Business Overview
11.1.3 Abbott Diagnostics Tumor Marker Testing Introduction
11.1.4 Abbott Diagnostics Revenue in Tumor Marker Testing Business (2019-2024)
11.1.5 Abbott Diagnostics Recent Development
11.2 Affymetrix
11.2.1 Affymetrix Company Detail
11.2.2 Affymetrix Business Overview
11.2.3 Affymetrix Tumor Marker Testing Introduction
11.2.4 Affymetrix Revenue in Tumor Marker Testing Business (2019-2024)
11.2.5 Affymetrix Recent Development
11.3 Agilent Technologies
11.3.1 Agilent Technologies Company Detail
11.3.2 Agilent Technologies Business Overview
11.3.3 Agilent Technologies Tumor Marker Testing Introduction
11.3.4 Agilent Technologies Revenue in Tumor Marker Testing Business (2019-2024)
11.3.5 Agilent Technologies Recent Development
11.4 Beckman Dickinson锛圔D锛�
11.4.1 Beckman Dickinson锛圔D锛� Company Detail
11.4.2 Beckman Dickinson锛圔D锛� Business Overview
11.4.3 Beckman Dickinson锛圔D锛� Tumor Marker Testing Introduction
11.4.4 Beckman Dickinson锛圔D锛� Revenue in Tumor Marker Testing Business (2019-2024)
11.4.5 Beckman Dickinson锛圔D锛� Recent Development
11.5 BioCurex
11.5.1 BioCurex Company Detail
11.5.2 BioCurex Business Overview
11.5.3 BioCurex Tumor Marker Testing Introduction
11.5.4 BioCurex Revenue in Tumor Marker Testing Business (2019-2024)
11.5.5 BioCurex Recent Development
11.6 BioModa
11.6.1 BioModa Company Detail
11.6.2 BioModa Business Overview
11.6.3 BioModa Tumor Marker Testing Introduction
11.6.4 BioModa Revenue in Tumor Marker Testing Business (2019-2024)
11.6.5 BioModa Recent Development
11.7 Clarient
11.7.1 Clarient Company Detail
11.7.2 Clarient Business Overview
11.7.3 Clarient Tumor Marker Testing Introduction
11.7.4 Clarient Revenue in Tumor Marker Testing Business (2019-2024)
11.7.5 Clarient Recent Development
11.8 Correlogic Systems
11.8.1 Correlogic Systems Company Detail
11.8.2 Correlogic Systems Business Overview
11.8.3 Correlogic Systems Tumor Marker Testing Introduction
11.8.4 Correlogic Systems Revenue in Tumor Marker Testing Business (2019-2024)
11.8.5 Correlogic Systems Recent Development
11.9 Epigenomics
11.9.1 Epigenomics Company Detail
11.9.2 Epigenomics Business Overview
11.9.3 Epigenomics Tumor Marker Testing Introduction
11.9.4 Epigenomics Revenue in Tumor Marker Testing Business (2019-2024)
11.9.5 Epigenomics Recent Development
11.10 Hologic
11.10.1 Hologic Company Detail
11.10.2 Hologic Business Overview
11.10.3 Hologic Tumor Marker Testing Introduction
11.10.4 Hologic Revenue in Tumor Marker Testing Business (2019-2024)
11.10.5 Hologic Recent Development
11.11 Roche Diagnostics
11.11.1 Roche Diagnostics Company Detail
11.11.2 Roche Diagnostics Business Overview
11.11.3 Roche Diagnostics Tumor Marker Testing Introduction
11.11.4 Roche Diagnostics Revenue in Tumor Marker Testing Business (2019-2024)
11.11.5 Roche Diagnostics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

Abbott Diagnostics
Affymetrix
Agilent Technologies
Beckman Dickinson锛圔D锛�
BioCurex
BioModa
Clarient
Correlogic Systems
Epigenomics
Hologic
Roche Diagnostics

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂